Trial NCT00072137

View at ClinicalTrials.gov 
Org. Study IDs: NCI-2009-00020
Secondary IDs: 050301 5585 CDR0000335473 NCI-2009-00020 P30CA072720 U01CA132194

Last trial update was posted on 2014-12-23

MeSH Interventions

Adjuvants, Vaccine Metronidazole Molgramostim Sargramostim Vaccines

MeSH Conditions

Carcinoma Urinary Bladder Neoplasms

Other Conditions

Bladder Adenocarcinoma Bladder Squamous Cell Carcinoma Bladder Urothelial Carcinoma Recurrent Bladder Carcinoma Stage I Bladder Cancer Stage II Bladder Cancer Stage III Bladder Cancer Stage IV Bladder Cancer

Stopping Reasons

N/A

Limitations And Caveats

N/A

Result Publications

N/A

Annotations

Category Annotations
No annotators decided on categories yet

Intervention Annotations
# Outdated Intervention Condition
Name Route DrugBank ID